Treating alcohol withdrawal with oral baclofen: A randomized, double-blind, placebo-controlled trial

Journal of Hospital Medicine

Volumn 6, Issue 8, 2011, Pages 469-474

  Lyon, Jeffrey E ^a   Khan, Raza A ^b   Gessert, Charles E ^c   Larson, Pamela M ^d   Renier, Colleen M ^c  

^a Essentia Health   (United States)

^b Unity Hospital   (United States)

^c ESSENTIA INSTITUTE OF RURAL HEALTH   (United States)

^d Essentia Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; LORAZEPAM; PLACEBO; CENTRAL MUSCLE RELAXANT;

ACUTE DISEASE; ADULT; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; DRUG MONITORING; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE; UNITED STATES; ALCOHOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADULT; ALCOHOLISM; BACLOFEN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; PLACEBOS; PROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 80053912128     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.928     Document Type: Article

References (29)

1. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005; 352( 6): 596-607.
2. D'Onofrio G, Bernstein E, Bernstein J, et al. Patients with alcohol problems in the emergency department, part 1: improving detection. SAEM Substance Abuse Task Force. Society for Academic Emergency Medicine. Acad Emerg Med. 1998; 5( 12): 1200-1209.
3. Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000; 160( 13): 1977-1989.
4. Chen CM, Yi H-Y. Trends in Alcohol-Related Morbidity Among Short-Stay Community Hospital Discharges, United States, 1979-2006. Surveillance Report #84. Arlington, VA: National Institute on Alcohol Abuse and Alcoholism; August 2008.
5. Bard MR, Goettler CE, Toschlog EA, et al. Alcohol withdrawal syndrome: turning minor injuries into a major problem. J Trauma. 2006; 61( 6): 1441-1446.
6. Bleich S, Bayerlein K, Hillemacher T, Degner D, Kornhuber J, Frieling H. An assessment of the potential value of elevated homocysteine in predicting alcohol-withdrawal seizures. Epilepsia. 2006; 47( 5): 934-938.
7. Dolman JM, Hawkes ND. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients. Alcohol Alcohol. 2005; 40( 6): 515-519.
8. Palmstierna T. A model for predicting alcohol withdrawal delirium. Psychiatr Serv. 2001; 52( 6): 820-823.
9. Balashov AM. [GABA-system and alcohol: does an "ethanol receptor" exist?] [review]. Zh Nevrol Psikhiatr Im S S Korsakova. 2007; Suppl 1: 56-62.
10. Wang LL, Yang AK, He SM, et al. Identification of molecular targets associated with ethanol toxicity and implications in drug development. Curr Pharm Des. 2010; 16( 11): 1313-1355.
11. Addolorato G, Leggio L, Agabio R, Colombo G, Gasbarrini G. Baclofen: a new drug for the treatment of alcohol dependence. Int J Clin Pract. 2006; 60( 8): 1003-1008.
12. Hill DR, Bowery NG. 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature. 1981; 290( 5802): 149-152.
13. Broadbent J, Harless WE. Differential effects of GABA(A) and GABA(B) agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2 J mice. Psychopharmacology (Berl). 1999; 141( 2): 197-205.
14. Kuriyama K. Cerebral GABA receptors. Alcohol Alcohol Suppl. 1994; 2: 181-186.
15. Daeppen J-B, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal. Arch Intern Med. 2002; 162( 10): 1117-1121.
16. Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacother. 2001; 21( 9): 1140-1144.
17. Kollef MH, Levy NT, Ahrens TS, Schaff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. 1998; 114: 541-548.
18. Addolorato G, Caputo F, Capristo E, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med. 2002; 112( 3): 226-229.
19. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II-preliminary clinical evidence. Alcohol Clin Exp Res. 2000; 24( 1): 67-71.
20. Addolorato G, Caputo F, Capristo E, et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 2002; 37( 5): 504-508.
21. Addolorato G, Leggio L, Abenavoli L, et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med. 2006; 119: 276.e213-276.e218.
22. Karlawish JHT, Casarett D, Propert KJ, James BD, Clark CM. Relationship between Alzheimer's disease severity and patient participation in decisions about their care. J Geriatr Psychiatry Neurol. 2002; 15( 2): 68-72.
23. Kraemer KL, Mayo-Smith MF, Calkins DR. Impact of age on the severity, course, and complications of alcohol withdrawal. Arch Intern Med. 1997; 157( 19): 2234-2241.
24. Kraemer KL, Mayo-Smith MF, Calkins DR. Independent clinical correlates of severe alcohol withdrawal. Substance Abuse. 2003; 24( 4): 197-209.
25. Addolorato G, Leggio L, Ferruli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind study. Lancet. 2007; 370: 1915-1922.
26. Flannery BA, Garbutt JC, Cody MW, et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res. 2004; 28( 10): 1517-1523.
27. Heberlein A, Bleich S, Kornhuber J, Hillemacher T. [Pharmacological treatment options for prevention of alcohol relapse]. Fortschr Neurol Psychiatr. 2008; 76( 7): 421-428.
28. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther. 2006; 111: 855-876.
29. Stallings W, Schrader S. Baclofen as prophylaxis and treatment for alcohol withdrawal: a retrospective chart review. J Okla State Med Assoc. 2007; 100( 9): 354-360.